Archive

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

See More +

September/October 2025

Evolutions in Patient Selection

How surgical candidacy has and has not changed.

View Issue

Why STREAMLINE® Surgical System Is Ideal for First-Line, Implant-Free Treatment

IJC Recap: Canaloplasty, Light-Adjustable Lenses, and Dropless Cataract Surgery

Editorially independent content, supported with advertising from New World Medical and Rayner

View Insert

Visionary Breakthroughs

Editorially independent content supported by Amaros, Atia Vision, Aurion Biotech, Azura Ophthalmics, EyeYon Medical, Iantrek, PLU Ophthalmic, SpyGlass Pharma, Tenpoint Therapeutics, and ViaLase.

View Supplement

July/August 2025

Pediatric Glaucoma

Updates on disease diagnosis and management in children.

View Issue

The Future of Glaucoma Laser Therapy

Rethinking Early Intervention in Glaucoma Care

Editorially independent content, supported with advertising from AbbVie, Glaukos, New World Medical, Nova Eye Medical, and Sight Sciences

View Insert

IJC Recap: Procedural Pharmaceuticals, Stability of Arcuate Keratotomy, and Work-Life Balance

Editorially independent content, supported with advertising from Lensar

View Insert

Evolving Strategies in Early-Stage Glaucoma Management

Sponsored and Supplied by The Fundingsland Group

View Supplement

May/June 2025

Intraoperative Pearls

Strategies for navigating surgical glaucoma scenarios.

View Issue

Innovative 360° Catheterization and Ease of Viscoelastic Delivery With VIA360™ Surgical System

March/April 2025

The Next Generation: Shaping the Future of the Field

View Issue

IJC Recap: Changes in MIGs Reimbursement, Monofocal IOL Technology, and Second-generation Anti-VEGFs

Editorially independent content, supported with advertising from ZEISS

View Insert

Canaloplasty: How it Works and Where it Fits in the MIGS Armamentarium

January/February 2025

Ready or Not?

Deliberations on whether certain approaches are ready for prime time.

View Issue

Safe and Effective Glaucoma Management With iDose TR (Travoprost Intracameral Implant) 75 mcg

IJC Recap: MIGS and the Cornea, a New Take on Punctal Occlusion, and a Preservative-Free Latanoprost Formulation

Editorially independent content, supported with advertising from Nordic Pharma, Glaukos, and Thea

View Insert

Archive

September/October 2025

Evolutions in Patient Selection

Why STREAMLINE® Surgical System Is Ideal for First-Line, Implant-Free Treatment

IJC Recap: Canaloplasty, Light-Adjustable Lenses, and Dropless Cataract Surgery

Visionary Breakthroughs

July/August 2025

Pediatric Glaucoma

The Future of Glaucoma Laser Therapy

Rethinking Early Intervention in Glaucoma Care

IJC Recap: Procedural Pharmaceuticals, Stability of Arcuate Keratotomy, and Work-Life Balance

Evolving Strategies in Early-Stage Glaucoma Management

May/June 2025

Intraoperative Pearls

Innovative 360° Catheterization and Ease of Viscoelastic Delivery With VIA360™ Surgical System

March/April 2025

The Next Generation: Shaping the Future of the Field

IJC Recap: Changes in MIGs Reimbursement, Monofocal IOL Technology, and Second-generation Anti-VEGFs

Canaloplasty: How it Works and Where it Fits in the MIGS Armamentarium

January/February 2025

Ready or Not?

Safe and Effective Glaucoma Management With iDose TR (Travoprost Intracameral Implant) 75 mcg

IJC Recap: MIGS and the Cornea, a New Take on Punctal Occlusion, and a Preservative-Free Latanoprost Formulation

10.19.25

10.18.25

10.18.25